FDA Issues Unsupported Safety Warning Regarding Surgical Robots for Cancer Treatment
FDA Law
OCTOBER 14, 2021
Food and Drug Administration (FDA) is reminding patients and health care providers that the safety and effectiveness of robotically-assisted surgical (RAS) devices for use in mastectomy procedures or in the prevention or treatment of breast cancer have not been established. These clearances are based on short-term (30 day) patient follow up.
Let's personalize your content